Polar Capital’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
$18.5M Buy
+1,250,000
New +$18.5M 0.14% 140
2015
Q2
Sell
-1,304
Closed -$545K 292
2015
Q1
$545K Buy
+1,304
New +$545K 0.01% 266
2014
Q4
Sell
-946
Closed -$184K 279
2014
Q3
$184K Buy
+946
New +$184K ﹤0.01% 267